It is reasonable that plasma levels of MASP2 were comparable between lupus patients and controls in the study by Troldborg et al, and increased serum levels of MASP2 in our study may indicate the dysregulated immunity in lupus patients, and the up‐regulated inflammatory response in lupus. This evidence concerns the gene MASP2 and systemic lupus erythematosus.